Tyagarajan Seshu
Chief Technology Officer
Tyagarajan Seshu has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 19, 2026.
On the most recent filing, Tyagarajan Seshu is listed as Chief Technology Officer at Candel Therapeutics, Inc. Inside the rolling window, Tyagarajan Seshu reported no open-market purchases and 2 open-market sales totaling $154K in CADL. The largest disclosed transaction in the window is a sale of 7,000 CADL shares on Aug 17, 2026, worth $84K.
Companies traded
Other insiders at CADL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$154K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Tyagarajan Seshu made?
Tyagarajan Seshu has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Tyagarajan Seshu trade?
Tyagarajan Seshu has filed SEC Form 4 disclosures for 1 company, including CADL.
When was Tyagarajan Seshu's most recent SEC Form 4 filing?
Tyagarajan Seshu's most recent SEC Form 4 filing on Tracefour is dated Aug 19, 2026.
What is Tyagarajan Seshu's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Tyagarajan Seshu is listed as Chief Technology Officer.
What is Tyagarajan Seshu's total buy and sell value in the current window?
Inside the rolling retention window, Tyagarajan Seshu bought $0 and sold $154K based on SEC Form 4 filings.
What was Tyagarajan Seshu's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,000 CADL shares on 2026-08-17, worth $84K, per SEC Form 4 filings.